XBIT vs XCUR

XBiotech Inc. vs Exicure, Inc. — Valuation Comparison 2026

XBIT

Biotechnology
XBiotech Inc.
Quality
4.7
out of 10
Value Trap
20
SAFE
Price
$2.44
Last close
Models
7/13
Active
VS

XCUR

Biotechnology
Exicure, Inc.
Quality
4.3
out of 10
Value Trap
60
DANGER
Price
$2.97
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType XBIT Fair ValueXBIT Upside XCUR Fair ValueXCUR Upside
Bayesian DCF Intrinsic $2.56 +4.8% $1.16 -60.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $4.70 +92.6% $0.08 -97.2%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for XBIT vs XCUR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

XBIT vs XCUR — Which Stock Is More Undervalued?

XBIT scores higher with a 4.7/10 quality rating vs XCUR's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing XBiotech Inc. (XBIT) and Exicure, Inc. (XCUR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

XBIT currently trades at $2.44 with a QOC of 4.7/10, while XCUR trades at $2.97 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).